May 28, 2026 U.S. FDA Approves DECNUPAZTM (pivekimab sunirine-pvzy) for Treatment of Adult Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options
May 28, 2026 DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States
